Cardlytics (NASDAQ:CDLX) Issues Quarterly Earnings Results, Beats Estimates By $0.12 EPS

08 May 2026, 23:36 by Teresa Graham · The Cerbat Gem

Cardlytics (NASDAQ:CDLX – Get Free Report) posted its earnings results on Thursday. The company reported ($0.25) EPS for the quarter, topping the consensus estimate of ($0.37) by $0.12, Zacks reports. The business had revenue of $34.32 million during the quarter, compared to analysts’ expectations of $37.20 million. Cardlytics had a negative return on equity of 656.95% and a negative net margin of 46.03%.

Here are the key takeaways from Cardlytics’ conference call:

Q1 adjusted EBITDA turned positive at $0.2M (vs -$4.1M a year ago) and adjusted contribution margin hit a record 60.6%, driven by a 38% reduction in adjusted operating expenses and cloud optimizations.
Billings and revenue remain materially below prior year — billings were $58.1M (-37% y/y) and revenue $34.3M (-39% y/y) — with ACPU down ~21% and MQUs at 197M after the Bank of America departure.
Management reports supply has stabilized and product momentum, including onboarding new FI portfolios later this year, the neobank Double Days promo that drove ~250k new activators, and three live partners on the Cardlytics Rewards Platform (CRP).
International strength and forward guidance — U.K. revenue grew >21% y/y, advertisers are consolidating spend with Cardlytics, and Q2 guidance targets sequential growth (~9–10%) across billings, revenue and adjusted contribution with improved adjusted EBITDA visibility.

Cardlytics Trading Down 18.1%

Shares of CDLX traded down $0.14 during mid-day trading on Friday, reaching $0.64. The company’s stock had a trading volume of 3,913,768 shares, compared to its average volume of 890,013. The stock has a market cap of $35.24 million, a PE ratio of -0.36 and a beta of 0.67. Cardlytics has a 52 week low of $0.57 and a 52 week high of $3.28. The company’s fifty day moving average price is $0.90 and its two-hundred day moving average price is $1.13.

Analysts Set New Price Targets

A number of analysts have recently issued reports on CDLX shares. Wall Street Zen upgraded Cardlytics from a “sell” rating to a “hold” rating in a research report on Saturday, April 4th. Lake Street Capital set a $1.00 price target on Cardlytics in a research report on Friday. Bank of America reiterated an “underperform” rating on shares of Cardlytics in a research report on Thursday, March 5th. Weiss Ratings reiterated a “sell (e+)” rating on shares of Cardlytics in a research report on Friday, April 10th. Finally, Evercore set a $1.00 price target on Cardlytics in a research report on Friday, March 6th. One analyst has rated the stock with a Hold rating and two have assigned a Sell rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Sell” and a consensus target price of $1.00.

Get Our Latest Stock Report on Cardlytics

Insider Buying and Selling

In related news, CEO Amit Gupta sold 69,833 shares of the firm’s stock in a transaction that occurred on Monday, April 6th. The stock was sold at an average price of $1.19, for a total transaction of $83,101.27. Following the transaction, the chief executive officer directly owned 987,387 shares in the company, valued at $1,174,990.53. This trade represents a 6.61% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, insider Nicholas Hollmeyer Lynton sold 40,296 shares of the firm’s stock in a transaction that occurred on Wednesday, April 1st. The stock was sold at an average price of $0.99, for a total value of $39,893.04. Following the transaction, the insider owned 167,856 shares in the company, valued at approximately $166,177.44. The trade was a 19.36% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last 90 days, insiders sold 324,111 shares of company stock valued at $330,154. Company insiders own 5.90% of the company’s stock.

Hedge Funds Weigh In On Cardlytics

Institutional investors and hedge funds have recently bought and sold shares of the stock. Bank of America Corp DE raised its stake in shares of Cardlytics by 262.7% during the third quarter. Bank of America Corp DE now owns 1,632,786 shares of the company’s stock valued at $3,968,000 after acquiring an additional 1,182,593 shares during the last quarter. Geode Capital Management LLC raised its stake in shares of Cardlytics by 3.3% during the fourth quarter. Geode Capital Management LLC now owns 654,472 shares of the company’s stock valued at $753,000 after acquiring an additional 20,908 shares during the last quarter. UBS Group AG raised its stake in shares of Cardlytics by 112.5% during the third quarter. UBS Group AG now owns 458,066 shares of the company’s stock valued at $1,113,000 after acquiring an additional 242,536 shares during the last quarter. Invesco Ltd. raised its stake in shares of Cardlytics by 38.1% during the fourth quarter. Invesco Ltd. now owns 170,122 shares of the company’s stock valued at $196,000 after acquiring an additional 46,973 shares during the last quarter. Finally, Jane Street Group LLC boosted its holdings in Cardlytics by 263.0% in the second quarter. Jane Street Group LLC now owns 162,427 shares of the company’s stock valued at $267,000 after acquiring an additional 117,687 shares in the last quarter. 68.10% of the stock is currently owned by institutional investors.

About Cardlytics

(Get Free Report)

Cardlytics, Inc operates a purchase intelligence and marketing platform that connects advertisers with consumers through bank and credit card transaction data. The company partners with financial institutions to analyze anonymized purchase information, enabling brands to deliver highly targeted offers and rewards directly to customers’ online and mobile banking channels. By leveraging real-time insights into consumer spending habits, Cardlytics helps marketers optimize campaign performance and measure return on ad spend more accurately than traditional digital advertising methods.